Vireo Health International (OTCMKTS:CCHWF)‘s stock had its “buy” rating reaffirmed by equities research analysts at Echelon Wealth Partners in a research note issued on Tuesday, AnalystRatings.com reports. They presently have a $9.50 price objective on the stock. Echelon Wealth Partners’ target price would suggest a potential upside of 181.90% from the company’s previous close.
A number of other equities research analysts have also recently weighed in on CCHWF. Canaccord Genuity reaffirmed a “buy” rating and issued a $13.00 price objective on shares of Vireo Health International in a research note on Thursday, September 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Vireo Health International in a research note on Wednesday, September 9th.
Shares of OTCMKTS CCHWF opened at $3.37 on Tuesday. Vireo Health International has a twelve month low of $0.78 and a twelve month high of $5.30. The company has a fifty day moving average price of $3.57.
About Vireo Health International
Columbia Care Inc produces and sells cannabis in the United States and the European Union. The company was founded in 2012 and is headquartered in New York, New York.
See Also: Marijuana Stocks Future Looks Bright
Receive News & Ratings for Vireo Health International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vireo Health International and related companies with MarketBeat.com's FREE daily email newsletter.